Filing Details
- Accession Number:
- 0001181431-14-009803
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-27 20:36:58
- Reporting Period:
- 2014-02-25
- Filing Date:
- 2014-02-27
- Accepted Time:
- 2014-02-27 20:36:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1276591 | Hansen Medical Inc | HNSN | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222357 | J Peter Mariani | C/O Hansen Medical, Inc. 800 East Middlefield Road Mountain View CA 94043 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-02-25 | 12,533 | $2.30 | 43,435 | No | 4 | F | Direct | |
Common Stock | Disposition | 2014-02-26 | 43,435 | $2.30 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-02-25 | 125,000 | $0.00 | 125,000 | $2.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
125,000 | 2024-02-25 | No | 4 | A | Direct |
Footnotes
- Shares withheld to satisfy withholding obligations in connection with the settlement of vested performance-based stock units. The vesting of the applicable performance based stock units was reported on the Form 4 filed by the Reporting Person with the Securities and Exchange Commission on February 13, 2014.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.27 to $2.33, inclusive. The reporting person will provide upon request by the Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- 25% of the option shares will vest and become exercisable on February 25, 2015 and the remaining option shares will vest and become exercisable ratably over the 36 months thereafter, subject to continuous service by the Reporting Person through each such date.